PRICE T ROWE ASSOCIATES INC /MD/ - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.7%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22
-66.7%
20,804
-63.2%
0.00%
Q2 2023$66
-20.5%
56,604
+3.8%
0.00%
Q1 2023$83
-31.4%
54,557
+13.1%
0.00%
Q4 2022$121
-99.9%
48,237
+4.6%
0.00%
Q3 2022$195,000
+119.1%
46,119
+45.2%
0.00%
Q2 2022$89,000
-53.2%
31,768
-4.4%
0.00%
Q1 2022$190,000
-30.7%
33,228
+10.8%
0.00%
Q4 2021$274,000
-52.0%
29,995
-43.8%
0.00%
Q3 2021$571,000
-27.3%
53,395
+5.5%
0.00%
Q2 2021$785,000
-15.7%
50,595
-11.9%
0.00%
Q1 2021$931,000
-37.6%
57,421
-18.5%
0.00%
Q4 2020$1,492,000
+40.1%
70,498
-1.9%
0.00%
Q3 2020$1,065,000
+14.8%
71,845
+13.8%
0.00%
Q2 2020$928,000
+27.8%
63,115
+2.1%
0.00%
Q1 2020$726,000
-28.1%
61,844
+43.9%
0.00%
Q4 2019$1,010,000
-9.0%
42,970
-28.4%
0.00%
Q3 2019$1,110,000
+25.9%
60,025
+26.5%
0.00%
Q2 2019$882,000
-23.4%
47,453
+0.7%
0.00%
Q1 2019$1,152,000
-5.0%
47,131
+0.8%
0.00%
Q4 2018$1,213,000
+12.6%
46,748
+37.4%
0.00%
Q3 2018$1,077,000
+218.6%
34,023
+290.9%
0.00%
Q2 2018$338,000
+36.3%
8,703
-43.2%
0.00%
Q3 2017$248,000
+72.2%
15,327
+47.0%
0.00%
Q2 2017$144,00010,4270.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders